Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2016 | 12-2015 | |
| Operating Expenses | 321 | 0 |
| Operating Income | -321 | N/A |
| Interest Expense | 11 | 0 |
| Pre-tax Income | -332 | 0 |
| Net Income Continuous | -332 | N/A |
| Net Income | $-332 | $N/A |
| EPS Basic Total Ops | -112.42 | N/A |
| EPS Basic Continuous Ops | -111.12 | N/A |
| EPS Diluted Total Ops | -112.42 | N/A |
| EPS Diluted Continuous Ops | -111.12 | N/A |
| EBITDA(a) | $-321 | $N/A |